Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (IQV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Iqvia Holdings Inc 2400 ELLIS ROAD DURHAM NC 27703 USA

www.iqvia.com Employees: 88,000 P: 919-998-2000

Sector:

Medical

Description:

IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I

Key Statistics

Overview:

Market Capitalization, $K 28,740,392
Enterprise Value, $K 42,484,392
Shares Outstanding, K 169,700
Float, K 166,985
% Float 98.40%
Short Interest, K 4,564
Short Float 2.69%
Days to Cover 3.69
Short Volume Ratio 0.44
% of Insider Shareholders 1.60%
% of Institutional Shareholders 89.62%

Financials:

Annual Sales, $ 16,310 M
Annual Net Income, $ 1,360 M
Last Quarter Sales, $ 4,364 M
Last Quarter Net Income, $ 514,000 K
EBIT, $ 3,326 M
EBITDA, $ 4,493 M

Growth:

1-Year Return -14.67%
3-Year Return -19.18%
5-Year Return -12.15%
5-Year Revenue Growth 43.59%
5-Year Earnings Growth 79.27%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 3.42 on 02/05/26
Next Earnings Date 05/05/26
Earnings Per Share ttm 10.87
EPS Growth vs. Prev Qtr 18.68%
EPS Growth vs. Prev Year 11.72%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IQV Ratios

Ratio
Price/Earnings ttm 15.74
Price/Earnings forward 14.80
Price/Earnings to Growth 1.65
Return-on-Equity % 30.50%
Return-on-Assets % 6.57%
Profit Margin % 8.34%
Debt/Equity 2.37
Price/Sales 1.78
Price/Cash Flow 9.57
Price/Book 4.39
Book Value/Share 38.93
Interest Coverage 3.18
60-Month Beta 1.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar